Director at Gemini Space Station (GEMI) receives 18,656 RSU equity grant

Rhea-AI Filing Summary

Filipakis Maria reported acquisition or exercise transactions in this Form 4 filing.

Gemini Space Station, Inc. reported that director Maria Filipakis received a grant of 18,656 shares of Class A common stock in the form of restricted stock units at no cash cost per share. Following this equity award, she holds 34,708 shares directly.

The 18,656 RSUs will vest over one year in four substantially equal quarterly installments beginning on May 20, 2026, conditioned on her continued service. Each RSU represents a contingent right to receive one share of Class A common stock, linking her compensation more closely to shareholder outcomes.

Insights

Equity Compensation Analyst

Routine director RSU grant aligns compensation with Gemini Space Station equity.

The filing shows Maria Filipakis, a director of Gemini Space Station, Inc., receiving 18,656 restricted stock units as compensation, with a stated price of $0.0000 per share. This indicates a non-cash equity award rather than an open-market purchase.

The RSUs vest in four substantially equal quarterly installments over a one-year period beginning on May 20, 2026, subject to continuous service. This structure is typical for board compensation and is designed to encourage ongoing service and alignment with shareholder interests.

After the grant, Filipakis directly holds 34,708 shares of Class A common stock. The absence of sales or derivative exercises in this filing suggests a straightforward compensation event, with no indication of discretionary trading activity or changes in her broader equity exposure beyond this award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Filipakis Maria

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	18,656	$0.00	--

Holdings After Transaction: Class A Common Stock — 34,708 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 18,656 RSUs Price per share for grant: $0.0000 per share Holdings after transaction: 34,708 shares +1 more

4 metrics

RSU grant size 18,656 RSUs Equity award to director Maria Filipakis

Price per share for grant $0.0000 per share Stated transaction price for RSU award

Holdings after transaction 34,708 shares Total Class A common shares directly held post-grant

Vesting start date May 20, 2026 First vesting date for RSUs, quarterly over one year

Key Terms

restricted stock units ("RSUs"), vest, contingent right, Class A common stock

4 terms

restricted stock units ("RSUs") financial

"Represents a grant of 18,656 restricted stock units ("RSUs"), which will vest over a one (1) year period"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest financial

"which will vest over a one (1) year period in four (4) substantially equal quarterly installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

contingent right financial

"Each RSU represents a contingent right to receive one share of Class A common stock."

Class A common stock financial

"Each RSU represents a contingent right to receive one share of Class A common stock."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Filipakis Maria

(Last) (First) (Middle)

600 THIRD AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10016

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gemini Space Station, Inc. [ GEMI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/14/2026		A		18,656(1)	A	$0	34,708	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of 18,656 restricted stock units ("RSUs"), which will vest over a one (1) year period in four (4) substantially equal quarterly installments beginning on May 20, 2026, subject to the reporting person's continuous service through such date. Each RSU represents a contingent right to receive one share of Class A common stock.

Remarks:

	Kate Freedman, as attorney-in-fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did the Form 4 report for Gemini Space Station (GEMI)?

The Form 4 reports that director Maria Filipakis received a grant of 18,656 restricted stock units of Gemini Space Station Class A common stock, at a stated price of $0.0000 per share, as part of her equity compensation rather than an open-market stock purchase.

How many Gemini Space Station (GEMI) shares does Maria Filipakis hold after this grant?

After the reported grant, Maria Filipakis directly holds 34,708 shares of Gemini Space Station Class A common stock. This total reflects the addition of 18,656 restricted stock units awarded in the transaction, subject to vesting terms tied to her continued service as a director.

How many restricted stock units did GEMI grant to director Maria Filipakis?

Gemini Space Station granted 18,656 restricted stock units (RSUs) of Class A common stock to director Maria Filipakis. Each RSU represents a contingent right to receive one share of Class A common stock, aligning a portion of her compensation with the company’s future share performance over time.

What are the vesting terms of Maria Filipakis’s RSUs at Gemini Space Station?

The 18,656 RSUs will vest over one year in four substantially equal quarterly installments beginning on May 20, 2026. Vesting is conditioned on Maria Filipakis’s continuous service, and each vested RSU converts into one share of Class A common stock upon settlement.

Was cash paid for the Gemini Space Station RSU grant to Maria Filipakis?

No cash was paid for the award; the RSUs were granted at a transaction price of $0.0000 per share. This indicates a standard, non-cash equity compensation grant for a director, rather than a purchase of shares on the open market at prevailing trading prices.

Does this GEMI Form 4 show any stock sales by Maria Filipakis?

The Form 4 does not report any stock sales by Maria Filipakis. It shows one acquisition transaction coded as a grant or award of 18,656 restricted stock units, increasing her direct holdings to 34,708 shares without any corresponding dispositions or derivative exercises in this filing.